| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.06 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.07 | 0.06 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.07 | 0.06 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.079 | 0.06 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | -0.097 | 0.06 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.07 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.07 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.07 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.066 | 0.07 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.062 | 0.07 |